Targeted Therapy clinical trials

Explore recruiting targeted therapy clinical trials.

Recruiting targeted therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Targeted Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial)

Netherlands, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

EORTC 1612-MG: Combination of targeted therapy (encorafenib and binimetinib) followed by combination of immunotherapy (ipilimumab and nivolumab) vs immediate combination of immunotherapy in patients with unresectable or metastatic melanoma with BRAF V600 mutation: an EORTC randomized phase II study (EBIN)

Netherlands, Italy, France, Germany, Spain, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

RAndomized, open label, multicenter study of Docetaxel versus an Androgen Receptor-targeted agent (abiraterone orenzalutamide) as first-line of therapy in mCRPC patients with adverse prognostic factors (RADAR-1 CRPC)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

HEROES: De-escalation of medical therapies in HER2-positive metastatic breast cancer in long-term persistent response and minimal residual disease undetectable in circulating tumor DNA

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment of metastatic colorectal cancer - FIRE-8 - AIO-KRK/YMO-0519

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer.

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Targeted Therapy trials by city

Targeted Therapy in Toronto Targeted Therapy in Vancouver Targeted Therapy in Montreal Targeted Therapy in Calgary Targeted Therapy in Edmonton Targeted Therapy in Ottawa Targeted Therapy in Winnipeg Targeted Therapy in Quebec City Targeted Therapy in Hamilton Targeted Therapy in Kitchener Targeted Therapy in London Targeted Therapy in Halifax Targeted Therapy in New York Targeted Therapy in Los Angeles Targeted Therapy in Chicago Targeted Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease